首页> 外文期刊>Nanomedicine >PEGylated crosslinked hyaluronic acid nanoparticles designed through a microfluidic platform for nanomedicine
【24h】

PEGylated crosslinked hyaluronic acid nanoparticles designed through a microfluidic platform for nanomedicine

机译:通过微流体平台进行纳米胺的聚乙二醇化交联透明质酸纳米粒子

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: A high versatile microfluidic platform is proposed to design, in a one-step strategy, PEGylated crosslinked hyaluronic acid nanoparticles (cHANPs) entrapping a magnetic resonance imaging contrast agent and a dye for multimodal imaging applications. Materials & methods: Clinically relevant biomaterials were shaped in the form of spherical NPs through a microfluidic flow focusing approach. A comparison between post processing and simultaneous PEGylation is reported to evaluate the potentiality of the chemical decoration of the cHANPs in microfluidics. Results: An accurate control of the NPs in terms of size, PEGylation and loading was obtained. Furthermore, in vitro cell viability is reported and their ability to boost the magnetic resonance imaging signal is also confirmed. Conclusion: The proposed microfluidic approach reveals its ability to overcome several limitations of the traditional processes and to become an easy-to-use platform for theranostic applications.
机译:目的:提出了一种高通用的微流体平台,以在一步策略中设计,捕获磁共振成像造影剂和用于多模式成像应用的磁共振成像造影剂和染料的聚乙二醇化交联透明质酸纳米粒子(Chanps)。 材料与方法:临床相关的生物材料通过微流体流动聚焦方法以球形NP的形式成形。 据报道,后处理和同时聚乙二醇化之间的比较,以评估微流体中CHANPS的化学装饰的潜力。 结果:获得尺寸,聚乙二醇化和装载方面对NPS的精确控制。 此外,报告了体外细胞活力,并且还确认了它们提高磁共振成像信号的能力。 结论:拟议的微流体方法揭示了其克服传统过程的几个局限性的能力,并成为治疗应用的易于使用平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号